Compare RVLV & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVLV | SDGR |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | 850 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2018 | 2020 |
| Metric | RVLV | SDGR |
|---|---|---|
| Price | $21.35 | $20.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $29.73 | $21.00 |
| AVG Volume (30 Days) | 752.8K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.64 | ★ 45.14 |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $1,225,682,000.00 | $255,869,000.00 |
| Revenue This Year | $10.96 | $0.76 |
| Revenue Next Year | $8.01 | $4.60 |
| P/E Ratio | $46.12 | ★ N/A |
| Revenue Growth | 8.48 | ★ 23.29 |
| 52 Week Low | $17.35 | $10.95 |
| 52 Week High | $31.68 | $23.02 |
| Indicator | RVLV | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 31.62 | 63.80 |
| Support Level | $18.48 | $17.23 |
| Resistance Level | $26.97 | N/A |
| Average True Range (ATR) | 0.88 | 1.01 |
| MACD | -0.26 | 0.08 |
| Stochastic Oscillator | 1.26 | 80.79 |
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.